Cargando…
Management of atrial fibrillation in patients taking targeted cancer therapies
Atrial fibrillation (AF) is frequently observed in patients being treated for cancer and can lead to increased morbidity and mortality in this population. With the use of newer, targeted cancer therapies, several drug-drug interactions have emerged that complicate the use of antiarrhythmic drugs (AA...
Autores principales: | Asnani, Aarti, Manning, Anastasia, Mansour, Moussa, Ruskin, Jeremy, Hochberg, Ephraim P., Ptaszek, Leon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048041/ https://www.ncbi.nlm.nih.gov/pubmed/32153998 http://dx.doi.org/10.1186/s40959-017-0021-y |
Ejemplares similares
-
Cryoballoon Catheter Ablation in Atrial Fibrillation
por: Ozcan, Cevher, et al.
Publicado: (2011) -
Left atrial appendage exclusion in atrial fibrillation
por: Rozen, Guy, et al.
Publicado: (2022) -
Impact of a Multidisciplinary Treatment Pathway for Atrial Fibrillation in the Emergency Department on Hospital Admissions and Length of Stay: Results of a Multi‐Center Study
por: Ptaszek, Leon M., et al.
Publicado: (2019) -
Emergency Department Visits for Atrial Fibrillation in the United States: Trends in Admission Rates and Economic Burden From 2007 to 2014
por: Rozen, Guy, et al.
Publicado: (2018) -
Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer
por: Ganatra, Sarju, et al.
Publicado: (2023)